跳至主要内容
临床试验/CTRI/2018/03/012643
CTRI/2018/03/012643尚未招募4 期

To study the role of Myo-inositol-D-chiro-inositol Combination Versus Combined Oral Contraceptives on Clinico-hormonal and Metabolic Parameters in Young Asian-Indian Girls with Polycystic Ovary Syndrome

Department of Obstetrics Gynaecology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Young girls in the age-group of 15-24 years (or atleast 2 years after the onset of menarche) with PCOS diagnosed by two out of the following criteria
  • a) Hyperandrogenism - Clinical(hirsutism
  • diagnosed by modified Ferriman -Gallwey
  • score more than or equal to 8/36) or
  • Biochemical (serum testosterone >0.5 ng/L)
  • b) Persistent oligo/anovulation characterized
  • by irregular menstrual cycles (19-90 days)
  • or absent menstrual cycles ( for a period
  • equivalent to previous 3 menstrual cycles)
  • c) Polycystic ovaries on ultrasound diagnosed
  • when ovarian volume more than 10 cu.cm.
  • d) Insulin resistance
  • 2) Patients who are willing to give consent for
  • the study and willing for follow-up.

排除标准

  • 1) Pregnancy.
  • 2) A known case of diabetes mellitus.
  • 3) Patients who are taking or had taken any
  • hormonal treatment including contraceptives
  • over the past 3 months.
  • 4) Patients who are taking or who had used
  • glucocorticoids, lipid-lowering drugs,
  • glucose-lowering drugs or anti-obesity drugs
  • within 3 months of the study.

研究者

发起方
Department of Obstetrics Gynaecology

相似试验